1887
Surveillance and outbreak report Open Access
Like 0

Abstract

In England and Wales, meningococcal disease caused by group W has historically been associated with outbreaks of disease among travellers to high-risk countries. Following a large outbreak associated with travel to the Hajj in 2000, the number of cases declined and, in 2008, only 19 laboratory-confirmed cases were identified nationally. In 2013, in the East Midlands region of England, eight cases of meningococcal disease caused by this serogroup were recorded, compared with six from 2011 to 2012. To explore this further, data for all cases with a date of onset between 1 January 2011 and 31 December 2013 were collected. Data collected included geographical location, clinical presentation and outcome. Fourteen cases were identified; two died as a result of their illness and two developed long-term health problems. No commonality in terms of geographical location, shared space or activities was identified, suggesting that group W is circulating endemically with local transmission. Clinical presentation was variable. Half presented with symptoms not typical of a classical meningococcal disease, including two cases of cellulitis, which may have implications for clinicians, in terms of timely identification and treatment, and public health specialists, for offering timely antibiotic chemoprophylaxis to close contacts.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2016.21.24.30259
2016-06-16
2017-11-22
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2016.21.24.30259
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/21/24/eurosurv-21-30259-3.html?itemId=/content/10.2807/1560-7917.ES.2016.21.24.30259&mimeType=html&fmt=ahah

References

  1. Ladhani SN, Flood JS, Ramsay ME, Campbell H, Gray SJ, Kaczmarski EB, et al. Invasive meningococcalhttp://www.ncbi.nlm.nih.gov/pubmed/22429756disease in England and Wales: implications for the introduction of new vaccines. Vaccine. 2012;30(24):3710-6.
  2. Aguilera JF, Perrocheau A, Meffre C, Hahné SW135 Working Group. Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000. Emerg Infect Dis. 2002;8(8):761-7.  https://doi.org/10.3201/eid0808.010422  PMID: 12141959 
  3. von Gottberg A, du Plessis M, Cohen C, Prentice E, Schrag S, de Gouveia L, et al. Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. Clin Infect Dis. 2008;46(3):377-86.  https://doi.org/10.1086/525260  PMID: 18181736 
  4. Nathan N, Rose AMC, Legros D, Tiendrebeogo SRM, Bachy C, Bjørløw E, et al. Meningitis serogroup W135 outbreak, Burkina Faso, 2002. Emerg Infect Dis. 2007;13(6):920-3.  https://doi.org/10.3201/eid1306.060940  PMID: 17553237 
  5. Collard JM, Issaka B, Zaneidou M, Hugonnet S, Nicolas P, Taha MK, et al. Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination. BMC Infect Dis. 2013;13(1):576.  https://doi.org/10.1186/1471-2334-13-576  PMID: 24313998 
  6. Hossain MJ, Roca A, Mackenzie GA, Jasseh M, Hossain MI, Muhammad S, et al. Serogroup W135 meningococcal disease, The Gambia, 2012. Emerg Infect Dis. 2013;19(9):1507-10.  https://doi.org/10.3201/eid1909.130077  PMID: 23965435 
  7. Lucidarme J, Hill DM, Bratcher HB, Gray SJ, du Plessis M, Tsang RS, et al. Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage. J Infect. 2015;71(5):544-52.  https://doi.org/10.1016/j.jinf.2015.07.007  PMID: 26226598 
  8. Harrison LH, Pelton SI, Wilder-Smith A, Holst J, Safadi MA, Vazquez JA, et al. The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease. Vaccine. 2011;29(18):3363-71.  https://doi.org/10.1016/j.vaccine.2011.02.058  PMID: 21376800 
  9. Public Health England (PHE). Meningococcal: the green book, chapter 22. London: PHE; March 2013. Available from: https://www.gov.uk/government/publications/meningococcal-the-green-book-chapter-22
  10. Thompson MJ, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367(9508):397-403.  https://doi.org/10.1016/S0140-6736(06)67932-4  PMID: 16458763 
  11. Vienne P, Ducos-Galand M, Guiyoule A, Pires R, Giorgini D, Taha M-K, et al. The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Clin Infect Dis. 2003;37(12):1639-42.  https://doi.org/10.1086/379719  PMID: 14689345 
  12. Wang JL, Liu DP, Yen JJ, Yu CJ, Liu HC, Lin CY, et al. Clinical features and outcome of sporadic serogroup W135 disease Taiwan. BMC Infect Dis. 2006;6(1):7.  https://doi.org/10.1186/1471-2334-6-7  PMID: 16420709 
  13. Faye A, Mariani-Kurkdjian P, Taha M-K, Angoulvant F, Antonios M, Aubertin G, et al. Clinical features and outcome of pediatric Neisseria meningitidis serogroup W135 infection: a report of 5 cases. Clin Infect Dis. 2004;38(11):1635-7.  https://doi.org/10.1086/421022  PMID: 15156454 
  14. Cartolano GL, Barbier C, Arnoult L, Simon D, Ricome JL, Hayon J. Fatal acute cellulitis due to Neisseria meningitidis. J Clin Microbiol. 2003;41(8):3996-7.  https://doi.org/10.1128/JCM.41.8.3996-3997.2003  PMID: 12904440 
  15. Porras MC, Martínez VC, Ruiz IM, Encinas PM, Fernandez MT, García J, et al. Miguel Carrascosa Porras, Victor Ca. Acute cellulitis: an unusual manifestation of meningococcal disease. Scand J Infect Dis. 2001;33(1):56-9.  https://doi.org/10.1080/003655401750064086  PMID: 11234980 
  16. Public Health England (PHE). National enhanced surveillance of vaccination programmes targeting invasive meningococcal disease in England. 2014. [Accessed 14 Jun 2016]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/484661/MeningoEnhancedSurveillancePlan_Final_Dec15.pdf
/content/10.2807/1560-7917.ES.2016.21.24.30259
Loading

Data & Media loading...

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error